Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Predictive validity of endpoints used in electrophysiological modelling of migraine in the trigeminovascular system.

Farkas B, Kardos P, Orosz S, Tarnawa I, Csekő C, Lévay G, Farkas S, Lendvai B, Kovács P.

Brain Res. 2015 Nov 2;1625:287-300. doi: 10.1016/j.brainres.2015.08.039. Epub 2015 Sep 7.

PMID:
26358146
2.

Recent advancements in anti-migraine drug research: focus on attempts to decrease neuronal hyperexcitability.

Bölcskei H, Farkas B, Kocsis P, Tarnawa I.

Recent Pat CNS Drug Discov. 2009 Jan;4(1):14-36. Review.

PMID:
19149711
3.

Blockers of voltage-gated sodium channels for the treatment of central nervous system diseases.

Tarnawa I, Bölcskei H, Kocsis P.

Recent Pat CNS Drug Discov. 2007 Jan;2(1):57-78. Review.

PMID:
18221218
4.

Concerted action of antiepileptic and antidepressant agents to depress spinal neurotransmission: Possible use in the therapy of spasticity and chronic pain.

Thán M, Kocsis P, Tihanyi K, Fodor L, Farkas B, Kovács G, Kis-Varga A, Szombathelyi Z, Tarnawa I.

Neurochem Int. 2007 Mar;50(4):642-52. Epub 2007 Jan 13.

PMID:
17280740
5.
6.

Tolperisone-type drugs inhibit spinal reflexes via blockade of voltage-gated sodium and calcium channels.

Kocsis P, Farkas S, Fodor L, Bielik N, Thán M, Kolok S, Gere A, Csejtei M, Tarnawa I.

J Pharmacol Exp Ther. 2005 Dec;315(3):1237-46. Epub 2005 Aug 26.

PMID:
16126840
7.

Simple pharmacological test battery to assess efficacy and side effect profile of centrally acting muscle relaxant drugs.

Farkas S, Berzsenyi P, Kárpáti E, Kocsis P, Tarnawa I.

J Pharmacol Toxicol Methods. 2005 Sep-Oct;52(2):264-73. Epub 2005 Jan 12.

PMID:
16125625
8.

NR2B receptors are involved in the mediation of spinal segmental reflex potentials but not in the cumulative motoneuronal depolarization in vitro.

Kocsis P, Kovács G, Farkas S, Horváth C, Szombathelyi Z, Tarnawa I.

Brain Res Bull. 2004 Aug 30;64(2):133-8.

PMID:
15342100
9.

NR2B containing NMDA receptor dependent windup of single spinal neurons.

Kovács G, Kocsis P, Tarnawa I, Horváth C, Szombathelyi Z, Farkas S.

Neuropharmacology. 2004 Jan;46(1):23-30.

PMID:
14654094
10.

Participation of AMPA- and NMDA-type excitatory amino acid receptors in the spinal reflex transmission, in rat.

Kocsis P, Tarnawa I, Szombathelyi Z, Farkas S.

Brain Res Bull. 2003 Apr 15;60(1-2):81-91.

PMID:
12725896
11.

2,3-benzodiazepine AMPA antagonists.

Tarnawa I, Vize ES.

Restor Neurol Neurosci. 1998;13(1-2):41-57.

PMID:
12671286
12.

[Mydeton: a centrally acting muscle relaxant drug from Gedeon Richter LTD].

Kocsis P, Tarnawa I, Kovács G, Szombathelyi Z, Farkas S.

Acta Pharm Hung. 2002;72(1):49-61. Hungarian.

PMID:
12426787
13.

Protective effect of the antiepileptic drug candidate talampanel against AMPA-induced striatal neurotoxicity in neonatal rats.

Világi I, Takács J, Gulyás-Kovács A, Banczerowski-Pelyhe I, Tarnawa I.

Brain Res Bull. 2002 Oct 15;59(1):35-40.

PMID:
12372546
14.

Comparison of spontaneous and evoked epileptiform activity in three in vitro epilepsy models.

Gulyás-Kovács A, Dóczi J, Tarnawa I, Détári L, Banczerowski-Pelyhe I, Világi I.

Brain Res. 2002 Aug 2;945(2):174-80.

PMID:
12126879
15.

Non-competitive AMPA antagonists of 2,3-benzodiazepine type.

Sólyom S, Tarnawa I.

Curr Pharm Des. 2002;8(10):913-39. Review.

PMID:
11945139
16.

Bicarbonate and thiocyanate ions affect the gating of gamma-aminobutyric acid(A) receptors in cultured rat cortical cells.

Maksay G, Fodor L, Bielik N, Tarnawa I.

Neurosci Lett. 2001 Oct 5;311(3):169-72.

PMID:
11578821
17.

New non competitive AMPA antagonists.

Abrahám G, Sólyom S, Csuzdi E, Berzsenyi P, Ling I, Tarnawa I, Hámori T, Pallagi I, Horváth K, Andrási F, Kapus G, Hársing LG Jr, Király I, Patthy M, Horváth G.

Bioorg Med Chem. 2000 Aug;8(8):2127-43.

PMID:
11003158
18.
19.

Structural analogues of some highly active non-competitive AMPA antagonists.

Hámori T, Sólyom S, Berzsenyi P, Andrási F, Tarnawa I.

Bioorg Med Chem Lett. 2000 May 1;10(9):899-902.

PMID:
10853655
20.

Differential modulation of the GYKI 53784-induced inhibition of AMPA currents by various AMPA-positive modulators in cerebellar Purkinje cells.

Kapus G, Bódi I, Pataki A, Gueritaud J, Székely JI, Tarnawa I.

Eur J Pharmacol. 2000 May 26;397(1):43-7.

PMID:
10844097
21.

Excitatory amino acids and synaptic transmission in embryonic rat brainstem motoneurons in organotypic culture.

Launey T, Ivanov A, Kapus G, Ferrand N, Tarnawa I, Gueritaud JP.

Eur J Neurosci. 1999 Apr;11(4):1324-34.

PMID:
10103128
22.

Effect of glutamate receptor antagonists on excitatory postsynaptic potentials in striatum.

Világi I, Kocsis P, Tarnawa I, Banczerowski-Pelyhe I.

Brain Res Bull. 1998 Aug;46(6):483-6.

PMID:
9744284
23.

Apparent antinociceptive and anti-inflammatory effects of GYKI 52466.

Székely JI, Kedves R, Máté I, Török K, Tarnawa I.

Eur J Pharmacol. 1997 Oct 8;336(2-3):143-54.

PMID:
9384226
24.

The functional study of kainate receptors--hopes and doubts.

Vizi ES, Mike A, Tarnawa I.

Trends Neurosci. 1997 Sep;20(9):396-7. No abstract available.

PMID:
9292966
26.

Activity of 2,3-benzodiazepines at native rat and recombinant human glutamate receptors in vitro: stereospecificity and selectivity profiles.

Bleakman D, Ballyk BA, Schoepp DD, Palmer AJ, Bath CP, Sharpe EF, Woolley ML, Bufton HR, Kamboj RK, Tarnawa I, Lodge D.

Neuropharmacology. 1996;35(12):1689-702.

PMID:
9076748
27.

Low extracellular magnesium unmasks N-methyl-D-aspartate-mediated graft-host connections in rat neocortex slice preparation.

Senatorov VV, Világi I, Tarnawa I, Banczerowski-Pelyhe I, Fülöp Z.

Neuroscience. 1995 Jan;64(2):443-58.

PMID:
7700532
28.

Age dependence of the glutamate antagonistic effect of GYKI 52466 in snail neurons.

Tarnawa I, Tóth S, Sármány J, Pénzes I.

Ann N Y Acad Sci. 1994 Jun 30;717:129-36. No abstract available.

PMID:
8030829
29.

Age-dependent modification of aspecific cellular effects of the benzodiazepine flunitrazepam.

Tóth S, Tarnawa I, Pénzes I, Sármány J, Tóth Z.

Arch Gerontol Geriatr. 1994 May-Jun;18(3):169-80.

PMID:
15374297
30.

An analysis of synaptic transmission to motoneurones in the cat spinal cord using a new selective receptor blocker.

Engberg I, Tarnawa I, Durand J, Ouardouz M.

Acta Physiol Scand. 1993 Jun;148(2):97-100.

PMID:
7688929
31.

Development of long-term potentiation in the somatosensory cortex of rats of different ages.

Világi I, Tarnawa I, Banczerowski-Pelyhe I.

Neurosci Lett. 1992 Jul 20;141(2):262-4.

PMID:
1436646
32.

Inhibition of hippocampal field potentials by GYKI 52466 in vitro and in vivo.

Tarnawa I, Molnár P, Gaál L, Andrási F.

Acta Physiol Hung. 1992;79(2):163-9.

PMID:
1363929
34.

Reflex inhibitory action of a non-NMDA type excitatory amino acid antagonist, GYKI 52466.

Tarnawa I, Farkas S, Berzsenyi P, Pátfalusi M, Andrási F.

Acta Physiol Hung. 1990;75 Suppl:277-8. No abstract available.

PMID:
2371888
35.

[Electrophysiological and morphological research on the integration of neocortical transplants with the recipient cortex performed on surviving slices].

Senatorov VV, Világi I, Tarnawa I, Bancherowski-Pelyhe I, Fülöp Z, Vartanyán GA.

Dokl Akad Nauk SSSR. 1990;315(6):1500-3. Russian. No abstract available.

PMID:
2088701
36.

Electrophysiological studies with a 2,3-benzodiazepine muscle relaxant: GYKI 52466.

Tarnawa I, Farkas S, Berzsenyi P, Pataki A, Andrási F.

Eur J Pharmacol. 1989 Aug 22;167(2):193-9.

PMID:
2574112
37.

Effects of some centrally acting muscle relaxants on spinal root potentials: a comparative study.

Farkas S, Tarnawa I, Berzsenyi P.

Neuropharmacology. 1989 Feb;28(2):161-73.

PMID:
2716970
38.

Morphine and [D-Met2,Pro5]enkephalinamide do not show specific neuroleptic activity.

Sineger E, Horváth K, Miglécz E, Tarnawa I, Andrási F, Székely JI.

Eur J Pharmacol. 1982 Jun 4;80(4):359-68.

PMID:
6125401
39.
40.

Attenuation of morphine tolerance and dependence by alpha-melanocyte stimulating hormone(alpha-MSH).

Székely JI, Miglécz E, Dunai-Kovács Z, Tarnawa I, Rónai AZ, Gráf L, Bajusz S.

Life Sci. 1979 May 21;24(21):1931-8. No abstract available.

PMID:
37395

Supplemental Content

Loading ...
Support Center